The product of these genes have been predicted to be involved in cancer cell invasion (MMP2, MMP9, ADAM23) (Roomi et al., 2009) and progression (IL6, EGF, and GLI1) (Knüpfer and Preiß, 2006, Makita et al., 2015) (Figure S6D; Table S5). The gene discussed is EGF; the disease is cancer.